CooperVision to Introduce MyDay® MiSight® 1 Day Lenses in Europe

CooperVision has announced the launch of its MyDay® MiSight® 1 Day contact lenses in the UK and select European markets. These lenses integrate advanced silicone hydrogel material with ActivControl® Technology, aimed at controlling the progression of myopia in children. Myopia, or nearsightedness, is a growing concern, with predictions indicating half of children born today may develop it by age 20.

Chief Commercial Officer, Debbie Olive, emphasized the company's dedication to myopia management with this new product, which has shown approximately a 50% reduction in myopia progression based on clinical trials. The innovative design offers continuous myopia control through the day.

Initially, these contact lenses will be available in specified parameters, offering a range that caters to various degrees of myopia. This launch is part of CooperVision's broader strategy to expand its evidence-based treatments for myopia.